Gene · 64783
Papers2,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential. | Front Cell Dev Biol | 2025 | 41403702 | PubTator, text mining | PubMed |
| Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma. | Transl Cancer Res | 2025 | 41378023 | PubTator, text mining | PubMed |
| Early Host-Virus RNA Interactions Reveal SPEN-Driven m 6 A Regulation as a Major Determinant of Henipavirus Infection. | bioRxiv | 2025 | 41332646 | PubTator, text mining | PubMed |
| RBM15 mediates m6A methylation modification of FOSB mRNA to promote dysfunction of trophoblast cells-a potential link to preeclampsia. | Hereditas | 2025 | 41272900 | PubTator, text mining | PubMed |
| Multi-texture synthesis through signal responsive neural cellular automata. | Sci Rep | 2025 | 41249326 | PubTator, text mining | PubMed |
| Hypoxia-Induced Histone Lactylation Drives Cisplatin Resistance in Bladder Cancer by Promoting RBM15-Dependent m6A Methylation of IGFBP3. | Research (Wash D C) | 2025 | 41199784 | PubTator, text mining | PubMed |
| The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. | Biomark Res | 2025 | 41194259 | PubTator, text mining | PubMed |
| Assessment of cyclists yielding to pedestrians at an unsignalized zebra crossing in Germany using drone video. | Sci Rep | 2025 | 41188319 | PubTator, text mining | PubMed |
| RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinoma. | J Cardiothorac Surg | 2025 | 41137052 | PubTator, text mining | PubMed |
| RETRACTION: Regulatory Mechanism of RNA Binding Motif Protein 15-Mediated N6 Methyladenosine Modification in Proliferation, Invasion, and Migration of Colorectal Cancer Cells. | Environ Toxicol | 2025 | 41133968 | PubTator, text mining | PubMed |
| Deacetylation of ACLY Mediates RNA M6A-Modification of NOXA and Promotes Chemoresistance of Colorectal Cancer. | Adv Sci (Weinh) | 2025 | 41038802 | PubTator, text mining | PubMed |
| Computational Analysis of Exosome-Derived Signature in TNBC: Integrating Single-Cell and Bulk Transcriptomics for Prognosis Prediction. | Clin Transl Sci | 2025 | 40994257 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. | Epigenomes | 2025 | 40981072 | PubTator, text mining | PubMed |
| Identification and experimental validation of biomarkers related to mitochondrial and programmed cell death in obsessive-compulsive disorder. | Sci Rep | 2025 | 40885831 | PubTator, text mining | PubMed |
| RBM15 promotes COAD progression by regulating the m6A modification of TMC5. | Hereditas | 2025 | 40883807 | PubTator, text mining | PubMed |
| The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression. | Sci Rep | 2025 | 40851023 | PubTator, text mining | PubMed |
| Clinical and prognostic significance of m6A hypomethylation and IGF2BP3 overexpression in gastric cancer: an integrated epigenomic-transcriptomic analysis. | Hum Genomics | 2025 | 40847370 | PubTator, text mining | PubMed |
| WTAP participates in the DNA damage response via an m6A-FOXM1-dependent manner in hepatocellular carcinoma. | Cell Death Discov | 2025 | 40846737 | PubTator, text mining | PubMed |
| RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype. | Hereditas | 2025 | 40830812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64783/papers?page=4